Chetan Lathia

Chetan Lathia has extensive experience in the field of clinical pharmacology and regulatory affairs. Chetan began their career in 1989 at American Cyanamid Company, where they served as a Senior Scientist in Pharmacodynamics Research. In this role, they led cardiovascular projects, managed pharmacokinetics plans, and represented clinical pharmacokinetics for various compounds in oncology, cardiovascular, obesity/metabolism, and anti-infectives.

Lathia then joined Bayer Pharmaceuticals in 1993 and held various positions over the course of almost two decades. As Senior Director of Clinical Pharmacology, they facilitated the development of biomarker and PK assessment plans for early development oncology compounds and those in Phase II & III development. Chetan also served as a Clinical Pharmacology Project Leader for Nexavar, where they developed and implemented the clinical pharmacology plan for the drug from IND to NDA. Alongside this, they played a vital role in interacting with regulatory agencies and ensuring compliance with clinical pharmacology requirements.

In 2012, Lathia moved to Alexion Pharmaceuticals as an Executive Director of Clinical Pharmacology. In this position, they managed the global functions of Clinical PK/PD, Pharmacometrics and Physiologically-based PK/PD Modeling & Simulation, Nonclinical PK/PD, and Bioanalytical Development. Chetan led a team of approximately 25 scientists and was responsible for various aspects of drug development.

In 2016, Lathia joined Intarcia Therapeutics, Inc. as the Vice President and Head of Clinical Pharmacology. During their tenure, they oversaw clinical pharmacology activities and played a crucial role in the development of the company's drug portfolio.

Most recently, Lathia has been working at BioXcel Therapeutics Inc. as the Senior VP & Head of Translational Medicine, Clinical Pharmacology & Regulatory Affairs. Chetan'sexact role within the company and the specific responsibilities they have taken on are not provided in the information given.

Overall, Chetan Lathia's work experience highlights their expertise in clinical pharmacology, regulatory affairs, and drug development across multiple therapeutic areas.

Chetan Lathia completed their Bachelor of Science degree in Pharmacy at L.M. College of Pharmacy between 1979 and 1983. Subsequently, they pursued a Ph.D. in Clinical Pharmacology/Pharmacokinetics at the Medical College of Virginia, Virginia Commonwealth University, which they received between 1984 and 1989.